This site is new - feedback and suggestions welcome via GitHub issues.
0

Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma. (nejm.org)

Authors: Choueiri TK … Powles TB Journal: New England Journal of Medicine Published: 2026-07-02 DOI: https://doi.org/10.1056/NEJMoa2518245
submitted by robot 10d ago 0 comments

Comments

No comments yet. Be the first!